<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
        {font-family:Helvetica;
        panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
        {font-family:Wingdings;
        panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
        {font-family:"Cambria Math";
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0in;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:#0563C1;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:#954F72;
        text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
        {mso-style-priority:34;
        margin-top:0in;
        margin-right:0in;
        margin-bottom:0in;
        margin-left:.5in;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
span.EmailStyle17
        {mso-style-type:personal-compose;
        font-family:"Calibri",sans-serif;
        color:windowtext;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-family:"Calibri",sans-serif;}
@page WordSection1
        {size:8.5in 11.0in;
        margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
        {page:WordSection1;}
/* List Definitions */
@list l0
        {mso-list-id:304622061;
        mso-list-type:hybrid;
        mso-list-template-ids:1074938588 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7;
        mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-.25in;
        font-family:Symbol;}
@list l0:level2
        {mso-level-number-format:bullet;
        mso-level-text:o;
        mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-.25in;
        font-family:"Courier New";}
@list l0:level3
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-.25in;
        font-family:Wingdings;}
@list l0:level4
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7;
        mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-.25in;
        font-family:Symbol;}
@list l0:level5
        {mso-level-number-format:bullet;
        mso-level-text:o;
        mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-.25in;
        font-family:"Courier New";}
@list l0:level6
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-.25in;
        font-family:Wingdings;}
@list l0:level7
        {mso-level-number-format:bullet;
        mso-level-text:\F0B7;
        mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-.25in;
        font-family:Symbol;}
@list l0:level8
        {mso-level-number-format:bullet;
        mso-level-text:o;
        mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-.25in;
        font-family:"Courier New";}
@list l0:level9
        {mso-level-number-format:bullet;
        mso-level-text:\F0A7;
        mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-.25in;
        font-family:Wingdings;}
ol
        {margin-bottom:0in;}
ul
        {margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:12.0pt">The Florida Department of Health (FDOH) has released four
<a href="http://www.floridahealth.gov/provider-and-partner-resources/research/funding-opportunity.html">
research funding opportunity announcements</a>. <o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;color:red">PLEASE NOTIFY COM Med-RA (<a href="mailto:research@med.fsu.edu"><span style="color:red">research@med.fsu.edu</span></a>) IF YOU INTEND TO RESPOND (OR PARTICIPATE IN A COLLABORATIVE RESPONSE) TO
 ANY OF THESE ANNOUNCEMENTS. Please note that three of these programs (*) limit the number of applications submitted by FSU. Additional internal paperwork and approvals may be required to submit your Letter of Intent.<o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt">Letters of Intent are required for all programs and must be reviewed by COM Med-RA three business days prior to submittal.
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoListParagraph" style="margin-left:0in;mso-list:l0 level1 lfo1"><b><span style="font-size:12.0pt">Ed and Ethel Moore Alzheimer’s Disease Research Program*</span></b><span style="font-size:12.0pt">: Letter of Intent due August 6, 2021 by 5:00 EST.
 Deadline for Med-RA review: August 3, 2021.<o:p></o:p></span></li></ul>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoListParagraph" style="margin-left:0in;mso-list:l0 level1 lfo1"><b><span style="font-size:12.0pt">William G. "Bill" Bankhead, Jr., and David Coley Cancer Research Program*:
</span></b><span style="font-size:12.0pt">Letter of Intent due August 11, 2021 by 5:00 EST. Deadline for Med-RA review: August 6, 2021.<o:p></o:p></span></li></ul>
<p class="MsoNormal" style="text-indent:3.0pt"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoListParagraph" style="margin-left:0in;mso-list:l0 level1 lfo1"><b><span style="font-size:12.0pt">James and Esther King Biomedical Research Program*:
</span></b><span style="font-size:12.0pt">Letter of Intent due August 11, 2021 by 5:00 EST. Deadline for Med-RA review: August 6, 2021.<o:p></o:p></span></li></ul>
<p class="MsoNormal" style="text-indent:3.0pt"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoListParagraph" style="margin-left:0in;mso-list:l0 level1 lfo1"><b><span style="font-size:12.0pt">Live Like Bella Pediatric Cancer Research Initiative:</span></b><span style="font-size:12.0pt"> Letter of Intent due August 20, 2021 by 5:00 EST.
 Deadline for Med-RA review: August 17, 2021.<o:p></o:p></span></li></ul>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt">FDOH is offering two on-line informational sessions for these funding opportunities:<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal" style="margin-left:.5in"><strong><span style="font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#202020">An Informational Webinar on Microsoft Teams will be conducted on July 23, 2021 and July 28,2021 from 9:00 AM – 10:30 AM EST
 to allow for questions and answers in real time.  Please join from your</span></strong><span style="font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#202020">
<strong><span style="font-family:"Helvetica",sans-serif">computer, tablet or smartphone:</span></strong><br>
 <br>
<a href="https://urldefense.com/v3/__https:/floridahealth.us19.list-manage.com/track/click?u=4dbaa4a3333ef33c6e55dfbc3&id=d573e5282d&e=05a57cde39__;!!PhOWcWs!mSvMngO1kl0I3fTAOlKn1-jy2nnx3Gpb9QS-b8bYFnLfLktAA3UTcf9ME1QtATAZXfw2$" target="_blank"><span style="color:#007C89">9:00
 AM July 23, 2021 FY21-22 FOA Overview and Q&A</span></a><br>
 <br>
<a href="https://urldefense.com/v3/__https:/floridahealth.us19.list-manage.com/track/click?u=4dbaa4a3333ef33c6e55dfbc3&id=25c945f6a5&e=05a57cde39__;!!PhOWcWs!mSvMngO1kl0I3fTAOlKn1-jy2nnx3Gpb9QS-b8bYFnLfLktAA3UTcf9ME1QtAcV4PuwL$" target="_blank"><span style="color:#007C89">9:00
 AM July 28, 2021 FY 21-22 FOA Overview and Q&A</span></a><o:p></o:p></span></p>
<p class="MsoNormal"><strong><span style="font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#202020"><o:p> </o:p></span></strong></p>
<p class="MsoNormal"><span style="font-size:12.0pt">Feel free to direct any questions to Med-RA at
<a href="mailto:research@med.fsu.edu">research@med.fsu.edu</a>.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>